Bioprime key facts
- Developer of bio-based technologies designed to aid the discovery of small molecules and microbes for the agriculture industry.
- Bioprime’s last known valuation is $12.2M.
- It has raised $8.8M; the latest was Later Stage VC ($6.0M) in Oct 2024.
- Notable investors include BIRAC, Venture Center, AIC ISB, Edaphon, I-Venture @ISB — 8 tracked in total.
- Status: Privately Held (backing).
- ·Watch Bioprime: the Monday email on marks, rounds and moves
Bioprime funding rounds
No funding rounds for Bioprime are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Bioprime valuation
Bioprime's last known valuation is $12.2 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.
Bioprime investors
8 investors are on record for Bioprime, including BIRAC, Venture Center, AIC ISB and Edaphon.
About Bioprime
Developer of bio-based technologies designed to aid the discovery of small molecules and microbes for the agriculture industry. The company's platform develops a systems-biology approach that combines research in plant physiology, biochemistry, ecology, and microbiomes, to develop innovative biologicals, to revolutionize agriculture and transform the lives of millions of farmers globally, promoting soil restoration and health, enabling farmers to effectively eliminate crop loss, temperature fluctuations, drought, resilient insects and diseases.
- Sector
- Materials and Resources
- HQ
- Pune, India
- Founded
- 2016
- Employees
- 76
- Website
- bioprimeagri.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Bioprime’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.